Kinetics of circulating TNF-α and TNF soluble receptors following surgery in a clinical model of sepsis

Cytokine

Volumn 8, Issue 12, 1996, Pages 938-943

  Neilson, D ^a   Kavanagh, J P ^a   Rao, P N ^b  

^a Department of Urology ^*  (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Percutaneous nephrolithotomy; Sepsis; Septicaemia; TNF soluble receptors; TNF

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTOXEMIA; FEMALE; HUMAN; MALE; NEPHROLITHOTOMY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEPSIS;

EID: 0030484084     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0126     Document Type: Article

References (15)

1. 1. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486.
2. 2. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD, Shires T, Cerami A (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
3. 3. Tartaglia LA, Goeddel DV (1992) Two TNF receptors. Immunol Today 13:151-153.
4. 4. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131.
5. 5. Seckinger P, Dayer J-M (1991) Natural inhibitors of TNF. In Aggarwal BB, Vilcek J (eds) Tumor Necrosis Factor. Structure, Function and Mechanism of Action, New York, Immunol Series 56:217-236.
6. 6. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329.
7. 7. Spinas GA, Keller U, Brockhaus M (1992) Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 90:533-536.
8. 8. Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J (1991) Prediction of septicaemia following endourological manipulation for stones in the upper urinary tract. J Urol 146:955-960.
9. 9. McCartney AC, Clark J, Lewi HJE (1985) Bacteriological study of renal calculi. Eur J Clin Microbiol 4:553-555.
10. 10. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548-1561.
11. 11. Froon AHM, Bemelmans MHA, Greve JW, van der Linden CJ, Buurman WA (1994) Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values. Crit Care Med 22:803-809.
12. 12. Giradin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, the J5 Study Group, Dayer J-M (1992) Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 76:20-23.
13. 13. Goldie AS, Fearon KCH, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC for the Sepsis Intervention Group (1995) Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. J Am Med Assoc 274:172-177.
14. 14. Brockhaus M, Bar-Khayim Y, Gurwicz S, Frensdorff A, Haran N (1992) Plasma tumor necrosis factor soluble receptors in chronic renal failure. Kidney Int 42:663-667.
15. 15. Knaus WA, Wagner DP, Draper EA, Zimmermann JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A, Harrell FE Jr (1991) The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100:1619-1636.